Gilead announces long-awaited price for Covid-19 drug remdesivir
Since remdesivir became the first medicine shown to have an impact on Covid-19, doctors, politicians, and Wall Street investors have engaged in a tense guessing game: What would its maker, Gilead Sciences, charge for the drug?
Now there is an answer.
Read Original Article: Gilead announces long-awaited price for Covid-19 drug remdesivir »
